Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
132 hedge funds and large institutions have $936M invested in Translate Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 27 reducing their positions, and 29 closing their positions.
126% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 27
1% less funds holding
Funds holding: 133 → 132 (-1)
3% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 29
21% less capital invested
Capital invested by funds: $1.19B → $936M (-$255M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less call options, than puts
Call options by funds: $2.12M | Put options by funds: $4.95M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$48.5M |
| 2 |
Goldman Sachs
New York
|
+$23.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$14.5M |
| 5 |
BlackRock
New York
|
+$9.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$21.8M |
| 2 |
KSCM
Key Square Capital Management
Stamford,
Connecticut
|
-$18.1M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$17.9M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$17.9M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
-$15M |
TBIO Hedge Fund Activity: Q3 2020 in Review
132 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2020, worth a combined $936M — down 21% from $1.19B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of TBIO and 28 opened new positions — a net loss of 1 holder — while 27 trimmed existing stakes and 61 added.
The largest buyer was State Street, adding an estimated $48.5M. The largest seller was Fidelity Investments, cutting an estimated $21.8M.
- 132 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2020, down from 133 in Q2 2020.
- Funds reported $936M of Translate Bio, Inc. Common Stock stock for Q3 2020, down 21% quarter-over-quarter.
- 28 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2020 and 29 closed out, a net change of -1 holder.
- The largest Translate Bio, Inc. Common Stock buyer in Q3 2020 was State Street, an estimated $48.5M added.
- The largest Translate Bio, Inc. Common Stock seller in Q3 2020 was Fidelity Investments, an estimated $21.8M sold.
Based on aggregated 13F filings for Q3 2020.